Outcome and predictors of treatment failure in early post-surgical prosthetic joint infections due to Staphylococcus aureus treated with debridement

作者: F. Vilchez , J.C. Martínez-Pastor , S. García-Ramiro , G. Bori , F. Maculé

DOI: 10.1111/J.1469-0691.2010.03244.X

关键词: SurgeryDebridementProsthesis RetentionImplantProsthetic jointStaphylococcus aureusProsthesisAntibioticsPost surgicalMedicine

摘要: Abstract Experience with debridement and prosthesis retention in early prosthetic joint infections (PJI) due to Staphylococcus aureus is scarce. The present study aimed evaluate the outcome predictors of failure. Patients prospectively registered an PJI S. 2 years follow-up were reviewed. Demographics, co-morbidity, type implant, clinical manifestations, surgical treatment, antimicrobial therapy recorded. Remission was defined when patient had no symptoms infection, retained C-reactive protein (CRP) ≤1 mg/dL. Univariate multivariate analysis performed. Fifty-three patients a mean ± SD age 70 10.8 Thirty-five on knee 18 hip prosthesis. duration intravenous oral antibiotics 10.6 6.7 88 45.9 days, respectively. After follow-up, 40 (75.5%) remission. Variables independently associated failure need for second (OR 20.4, 95% CI 2.3–166.6, p 0.006) CRP > 22 mg/dL 9.8, 1.5–62.5, 0.01). onset infection within 25 days after arthroplasty at limit significance 8.3, 0.8–85.6, 0.07). Debridement followed by short period reasonable treatment option aureus. Predictors control first arthroplasty.

参考文章(22)
J.-E. Berdal, I. Skra°mm, P. Mowinckel, P. Gulbrandsen, J.V. Bjørnholt, Use of rifampicin and ciprofloxacin combination therapy after surgical debridement in the treatment of early manifestation prosthetic joint infections Clinical Microbiology and Infection. ,vol. 11, pp. 843- 845 ,(2005) , 10.1111/J.1469-0691.2005.01230.X
A. Soriano, S. García, G. Bori, M. Almela, X. Gallart, F. Macule, J. Sierra, J.A. Martínez, S. Suso, J. Mensa, Treatment of acute post-surgical infection of joint arthroplasty Clinical Microbiology and Infection. ,vol. 12, pp. 930- 933 ,(2006) , 10.1111/J.1469-0691.2006.01463.X
M. Monreal Portella, M. Javaloyas De Morlius, Tratamiento antibiótico por vía oral de la osteomielitis bacteriana del adulto: resultados tras dos años de seguimiento Medicina Clinica. ,vol. 113, pp. 488- 489 ,(1999)
A. F. Widmer, A. Gaechter, P. E. Ochsner, W. Zimmerli, Antimicrobial Treatment of Orthopedic Implant-related Infections with Rifampin Combinations Clinical Infectious Diseases. ,vol. 14, pp. 1251- 1253 ,(1992) , 10.1093/CLINIDS/14.6.1251
Werner Zimmerli, Andrej Trampuz, Peter E. Ochsner, Prosthetic-Joint Infections The New England Journal of Medicine. ,vol. 351, pp. 1645- 1654 ,(2004) , 10.1056/NEJMRA040181
Marta Monzón, Concepción Oteiza, José Leiva, Marta Lamata, Beatriz Amorena, Biofilm testing of Staphylococcus epidermidis clinical isolates: low performance of vancomycin in relation to other antibiotics. Diagnostic Microbiology and Infectious Disease. ,vol. 44, pp. 319- 324 ,(2002) , 10.1016/S0732-8893(02)00464-9
E. Moran, S. Masters, A.R. Berendt, P. McLardy-Smith, I. Byren, B.L. Atkins, Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention. Journal of Infection. ,vol. 55, pp. 1- 7 ,(2007) , 10.1016/J.JINF.2007.01.007
Werner Zimmerli, Andreas F Widmer, Marianne Blatter, R Frei, Peter E Ochsner, Role of Rifampin for Treatment of Orthopedic Implant–Related Staphylococcal Infections A Randomized Controlled Trial JAMA. ,vol. 279, pp. 1537- 1541 ,(1998) , 10.1001/JAMA.279.19.1537
A Soriano, J Gomez, L Gomez, JR Azanza, R Pérez, F Romero, M Pons, F Bella, M Velasco, J Mensa, None, Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections. European Journal of Clinical Microbiology & Infectious Diseases. ,vol. 26, pp. 353- 356 ,(2007) , 10.1007/S10096-007-0289-1